Treatment of Open Wound Infections
The recommended treatment for open wound infections includes thorough wound debridement, appropriate wound care, and targeted antibiotic therapy based on infection severity, with mild infections often requiring only aerobic gram-positive coverage while severe infections need broad-spectrum antibiotics. 1
Infection Assessment and Classification
Proper management begins with assessing the severity of infection:
- Mild infection: Localized cellulitis/erysipelas without systemic signs
- Moderate infection: More extensive infection with systemic signs (temperature >38.5°C, heart rate >110 beats/minute, respiratory rate >24 breaths/minute, or abnormal white blood cell count)
- Severe infection: Patients with systemic toxicity, failed oral antibiotics, or signs of deeper infection (bullae, skin sloughing, hypotension) 1
Initial Wound Management
Wound cleansing and debridement:
- Cleanse wound thoroughly
- Perform surgical debridement of all devitalized tissue
- For severe infections with signs of systemic toxicity, urgent surgical consultation is recommended 1
Obtain appropriate cultures:
- Send deep tissue specimens obtained by biopsy or curettage after wound cleansing and debridement
- Avoid swab specimens, especially from inadequately debrided wounds, as they provide less accurate results 1
Antibiotic Therapy
For Mild Infections:
- Target aerobic gram-positive cocci (primarily Staphylococcus aureus and streptococci)
- Oral options:
- Dicloxacillin or cephalexin (for MSSA)
- Doxycycline, clindamycin, or sulfamethoxazole-trimethoprim (if MRSA suspected) 1
For Moderate Infections:
- Oral or parenteral therapy depending on clinical presentation
- Recommended regimens:
- Amoxicillin-clavulanate (875/125 mg twice daily)
- Cefuroxime (500 mg twice daily)
- Clindamycin (300-450 mg three times daily) 1
For Severe Infections:
- Initiate broad-spectrum empiric therapy pending culture results:
- Vancomycin (15 mg/kg IV every 6h) plus either:
- Piperacillin-tazobactam (3.37g every 6-8h IV)
- Ampicillin-sulbactam (1.5-3.0g every 6h IV)
- A carbapenem (e.g., ertapenem 1g daily IV) 1
- Vancomycin (15 mg/kg IV every 6h) plus either:
Duration of Therapy
- Soft tissue infections: 7-14 days is typically sufficient
- Mild infections: 7-10 days
- Moderate to severe infections: 14-21 days 1
- Continue antibiotics until, but not beyond, resolution of infection signs (not through complete wound healing) 1
Special Considerations
Diabetic Foot Infections
- Require more aggressive management due to compromised circulation and immune response
- May need longer courses of antibiotics (2-3 weeks for moderate to severe infections) 1
Human or Animal Bites
- Require coverage for oral flora
- Amoxicillin-clavulanate is the preferred agent 1
Tetanus Prophylaxis
- Administer tetanus toxoid to patients without vaccination within 10 years
- Tdap is preferred over Td if not previously given 1
Topical Antimicrobials
- Consider for mild superficial infections or as adjuncts to systemic therapy
- Silver sulfadiazine, iodine-based preparations, or other antimicrobial dressings may be beneficial
- Maintenance debridement with topical antimicrobials is more effective than antibiotics alone for controlling biofilm in chronic wounds 2
Common Pitfalls to Avoid
Overuse of antibiotics: Clinically uninfected wounds should not be treated with antibiotics 1
Inadequate debridement: Antibiotic therapy is often insufficient unless combined with appropriate wound care 1
Inappropriate cultures: Swab specimens from inadequately debrided wounds provide inaccurate results 1
Prolonged antibiotic therapy: Continuing antibiotics beyond resolution of infection signs contributes to antibiotic resistance 3
Neglecting wound closure: Early wound closure can reduce the risk of serious wound infections, especially in patients with full-thickness wounds 4
By following these guidelines, clinicians can effectively manage open wound infections while promoting appropriate antibiotic stewardship and optimal wound healing outcomes.